Challenges and opportunities in developing Actinium-225 radiopharmaceuticals. Dhiman D, Vatsa R, Sood A. Nucl Med Commun 2022;43:970-977.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dhiman D, Vatsa R, Sood A. Challenges and opportunities in developing Actinium-225 radiopharmaceuticals. Nucl Med Commun 2022;43:970-977.
PMID: 35950353